journal article·2020-12

Proteasome activity regulated by charged gold nanoclusters: Implications for neurodegenerative diseases

Xiaochuan Ma, Sangyun Lee, Xingshu Fei, Ge Fang, Tien Huynh, Chunying Chen, Zhifang Chai, Cuicui Ge, Ruhong Zhou

Nano Today· Volume 35
Publisher page

Abstract

Abstract The 20S proteasome, the catalytic core particle of 26S proteasome, degrades a wide range of intracellular proteins, which is essential for many cellular processes. Herein, we have found that the 20S proteasome activity is either up- or down-regulated by introducing gold nanoclusters (AuNCs) coated with nine peptide tails in two different forms, AuNC(−) and AuNC(+), each encoding five consecutive negatively or positively charged amino acids. Molecular dynamics simulations reveal that AuNC(−) and AuNC(+) bind to different surfaces of the 20S proteasome, and respectively facilitate or hinder the opening of the central gate of 20S proteasome for substrate access to the internal active site for protein degradation. Furthermore, the addition of AuNC(-) induces protective effects in a cell model of Parkinson’s disease, by up-regulating the proteasome activity under the condition of reduced ATP production, and enhancing the degradation of overexpressed α-synuclein, thereby attenuating the loss of cell viability. Our findings suggest the potential application of gold nanoclusters for treating neurodegenerative diseases.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Ubiquitin and proteasome pathways · Protease and Inhibitor Mechanisms · Alzheimer's disease research and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Ge · Arch. Toxicol. · 2015 · 89 · 51910.1007/s00204-015-1458-0 ↗
2. Kane · Biotechnol. Progr. · 2010 · 23 · 31610.1021/bp060388n ↗
3. Lara · ACS Nano · 2017 · 11 · 188410.1021/acsnano.6b07933 ↗
4. Gao · Biomaterials · 2019 · 194 · 3610.1016/j.biomaterials.2018.12.013 ↗
5. Lynch · Nano Today · 2008 · 3 · 4010.1016/S1748-0132(08)70014-8 ↗
6. Nel · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
7. Lynch · Nat. Nanotechnol. · 2009 · 4 · 54610.1038/nnano.2009.248 ↗
8. Fleischer · Acc. Chem. Res. · 2014 · 47 · 265110.1021/ar500190q ↗
9. Blanco · Nat. Biotechnol. · 2015 · 33 · 94110.1038/nbt.3330 ↗
10. Boselli · Angew. Chem. Int. Ed. Engl. · 2017 · 56 · 421510.1002/anie.201700343 ↗
11. Herda · J. Am. Chem. Soc. · 2017 · 139 · 11110.1021/jacs.6b12297 ↗
12. Kelly · Nat. Nanotechnol. · 2015 · 10 · 47210.1038/nnano.2015.47 ↗
13. Lo Giudice · Nat. Commun. · 2016 · 7 · 1347510.1038/ncomms13475 ↗
14. Hershko · Nat. Med. · 2003 · 67 · 1
15. Ciechanover · Cell · 1994 · 79 · 1310.1016/0092-8674(94)90396-4 ↗
16. Bence · Science · 2001 · 292 · 155210.1126/science.292.5521.1552 ↗
17. Coux · Annu. Rev. Biochem. · 1996 · 65 · 80110.1146/annurev.bi.65.070196.004101 ↗
18. Bard · Annu. Rev. Biochem. · 2018 · 87 · 69710.1146/annurev-biochem-062917-011931 ↗
19. Rivett · Curr. Opin. Immunol. · 1998 · 10 · 11010.1016/S0952-7915(98)80040-X ↗
20. Tanaka · J. Biol. Chem. · 1986 · 261 · 5197
21. Ciechanover · Neuron · 2003 · 40 · 42710.1016/S0896-6273(03)00606-8 ↗
22. Olanow · Mov. Disord. · 2006 · 21 · 180610.1002/mds.21013 ↗
23. Jenner · J. Neurochem. · 2003 · 8510.1046/j.1471-4159.85.s2.1_2.x ↗
24. Lan · Mol. Med. Rep. · 2014 · 11 · 165510.3892/mmr.2014.3011 ↗
25. Keller · Free Radic. Biol. Med. · 2000 · 29 · 103710.1016/S0891-5849(00)00412-3 ↗
26. Tribello · Comput. Phys. Commun. · 2014 · 185 · 60410.1016/j.cpc.2013.09.018 ↗
27. Kumar · J. Comput. Chem. · 1992 · 13 · 101110.1002/jcc.540130812 ↗
28. Grossfield · 2020
29. Denizot · J. Immunol. Methods · 1986 · 89 · 27110.1016/0022-1759(86)90368-6 ↗
30. Structure of 20S proteasome from yeast at 2.4 A resolution10.1038/386463a0 ↗
31. Ben-Nissan · Biomolecules · 2014 · 4 · 86210.3390/biom4030862 ↗
32. Trader · Biochim. Biophys. Act. · 2017 · 1861 · 89210.1016/j.bbagen.2017.01.003 ↗
33. Thibaudeau · Nat. Commun. · 2018 · 9 · 109710.1038/s41467-018-03509-0 ↗
34. Förster · Mol. Cell · 2005 · 18 · 58910.1016/j.molcel.2005.04.016 ↗
35. Whitby · Nature · 2000 · 408 · 11510.1038/35040607 ↗
36. Wehmer · Proc. Natl. Acad. Sci. U. S. A. · 2017 · 114 · 130510.1073/pnas.1621129114 ↗
37. Eisele · Cell Rep. · 2018 · 24 · 130110.1016/j.celrep.2018.07.004 ↗
38. Chen · Proc. Natl. Acad. Sci. U. S. A. · 2016 · 113 · 1299110.1073/pnas.1614614113 ↗
39. Huber · Cell · 2012 · 148 · 72710.1016/j.cell.2011.12.030 ↗
40. Gelinas · J. Neurosci. Res. · 2002 · 70 · 9010.1002/jnr.10315 ↗
41. Dal Vechio · Free Radical Biol. Med. · 2013 · 67C · 304
42. Demasi · J. Neurol. Neuromed. · 2017 · 2 · 110.29245/2572.942X/2017/8.1146 ↗
43. Han · Nat. Commun. · 2014 · 5 · 563310.1038/ncomms6633 ↗
44. Elagnaf · FASEB J. · 2006 · 20 · 41910.1096/fj.03-1449com ↗
45. Bandopadhyay · Trends Mol. Med. · 2010 · 16 · 2710.1016/j.molmed.2009.11.004 ↗
46. Evert · Biochemistry · 2018 · 57 · 421410.1021/acs.biochem.8b00579 ↗
47. Wang · Sci. Signal. · 2010 · 3 · ra88
48. Aiken · Mol. Cell Proteomics · 2011 · 10 · R11010.1074/mcp.M110.006924 ↗
49. Smart · J. Mol. Graph. · 1996 · 14 · 35410.1016/S0263-7855(97)00009-X ↗
50. Bakan · Bioinformatics · 2011 · 27 · 157510.1093/bioinformatics/btr168 ↗
51. VMD: visual molecular dynamics10.1016/0263-7855(96)00018-5 ↗